Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.580
-0.170 (-6.18%)
At close: Sep 25, 2026, 4:00 PM EDT
2.626
+0.046 (1.80%)
After-hours: Sep 25, 2026, 7:13 PM EDT
Editas Medicine Employees
Editas Medicine had 87 employees as of December 31, 2025. The number of employees decreased by 159 or -64.63% compared to the previous year.
Employees
87
Change (1Y)
-159
Growth (1Y)
-64.63%
Revenue / Employee
$540,287
Profits / Employee
-$849,989
Market Cap
396.24M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 87 | -159 | -64.63% |
| Dec 31, 2024 | 246 | -19 | -7.17% |
| Dec 31, 2023 | 265 | 39 | 17.26% |
| Dec 31, 2022 | 226 | -38 | -14.39% |
| Dec 31, 2021 | 264 | 29 | 12.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 200 |
| Kyverna Therapeutics | 149 |
| Arcturus Therapeutics Holdings | 111 |
| Scribe Therapeutics | 82 |
| Prelude Therapeutics | 79 |
| Rezolute | 68 |
| Prothena Corporation | 67 |
| Atea Pharmaceuticals | 55 |
EDIT News
- 2 days ago - Editas slips amid pressure on gene-editing sector after Anthropic update - TheFly
- 2 days ago - Editas Medicine upgraded to Buy at Guggenheim on EDIT-401 potential - TheFly
- 2 days ago - Editas Medicine upgraded to Buy from Neutral at Guggenheim - TheFly
- 15 days ago - Editas Medicine Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 16 days ago - Editas Medicine Reports Inducement Grants to New Chief Medical Officer - GlobeNewsWire
- 17 days ago - Editas Medicine Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 17 days ago - Editas Medicine appoints Dan Ory as chief medical officer - TheFly
- 17 days ago - Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer - GlobeNewsWire